Advertisement
Screener

GEOVAX LABS, INC. (GOVX) Form D

GEOVAX LABS, INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2019-11-01: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-07-16; Total offering amount $3,256,534.
  • 2019-11-01: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-07-24; Total offering amount $700,000.
  • 2019-11-01: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-07-24; Total offering amount $700,000.
  • 2009-09-30: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2009-09-21; Total offering amount $1,500,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2019-11-01
D/A
Rule 506(b)Equity2019-07-16$3,256,534$3,256,534$02
2019-11-01
D/A
Rule 506(b)Equity2019-07-24$700,000$700,000$02
2019-11-01Rule 506(b)Equity2019-07-24$700,000$700,000$02
2009-09-30Rule 506Equity2009-09-21$1,500,000$1,500,000$01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Genprex, Inc. (GNPX)United States$0.003B-0.02
Alaunos Therapeutics, Inc. (TCRT)United States$0.003B-1.44
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
Sunshine Biopharma Inc. (SBFM)$0.003B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
ORAGENICS INC (OGEN)United States$0.002B